Sarv Bio Pharmaceutical Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 03-11-2024
- Paid Up Capital ₹ 4.10 M
as on 03-11-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.61 Cr
as on 03-11-2024
- Revenue %
(FY 2023)
- Net Worth 5388.57%
(FY 2023)
- Total Assets 752.01%
(FY 2023)
About Sarv Bio Pharmaceutical Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.10 M.
The company currently has active open charges totaling ₹10.61 Cr.
Vijay Aggarwal and Anirudh Aggarwal serve as directors at the Company.
- CIN/LLPIN
U24299HR2021PTC092237
- Company No.
092237
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sarv Bio Pharmaceutical Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Aggarwal  | Director | 15-Jan-2021 | Current |
| Anirudh Aggarwal | Director | 15-Jan-2021 | Current |
Financial Performance of Sarv Bio Pharmaceutical Research.
Sarv Bio Pharmaceutical Research Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 5388.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sarv Bio Pharmaceutical Research?
In 2023, Sarv Bio Pharmaceutical Research had a promoter holding of 8.54% and a public holding of 91.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sarv Bio Labs Private LimitedActive 19 years 11 monthsVijay Aggarwal and Anirudh Aggarwal are mutual person
Ecogenics Solutions Private LimitedActive 5 years 1 monthVijay Aggarwal and Anirudh Aggarwal are mutual person
- Jai Ambey Containers Private LimitedActive 25 years 10 months
Vijay Aggarwal and Anirudh Aggarwal are mutual person
- Sarv Bio Pharma Private LimitedActive 4 years 17 days
Vijay Aggarwal and Anirudh Aggarwal are mutual person
- Micro Motion India Private LimitedActive 33 years 5 months
Vijay Aggarwal and Anirudh Aggarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Feb 2024 | ₹1.50 Cr | Open |
Hdfc Bank Limited Creation Date: 01 Dec 2022 | ₹9.11 Cr | Open |
How Many Employees Work at Sarv Bio Pharmaceutical Research?
Sarv Bio Pharmaceutical Research has a workforce of 81 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarv Bio Pharmaceutical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarv Bio Pharmaceutical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
